These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24228251)

  • 41. Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.
    Huang Y; Wu Z; Riwanto M; Gao S; Levison BS; Gu X; Fu X; Wagner MA; Besler C; Gerstenecker G; Zhang R; Li XM; DiDonato AJ; Gogonea V; Tang WH; Smith JD; Plow EF; Fox PL; Shih DM; Lusis AJ; Fisher EA; DiDonato JA; Landmesser U; Hazen SL
    J Clin Invest; 2013 Sep; 123(9):3815-28. PubMed ID: 23908111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The Role of Anti-Oxidative Stress in HDL].
    Kotani K
    Rinsho Byori; 2016 Jan; 64(1):44-8. PubMed ID: 27192796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
    Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
    Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The three-gene paraoxonase family: physiologic roles, actions and regulation.
    Précourt LP; Amre D; Denis MC; Lavoie JC; Delvin E; Seidman E; Levy E
    Atherosclerosis; 2011 Jan; 214(1):20-36. PubMed ID: 20934178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress.
    Deakin SP; Bioletto S; Bochaton-Piallat ML; James RW
    Free Radic Biol Med; 2011 Jan; 50(1):102-9. PubMed ID: 20850524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1.
    Kar S; Patel MA; Tripathy RK; Bajaj P; Pande AH
    Biochim Biophys Acta; 2013 Dec; 1831(12):1714-20. PubMed ID: 23973798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity.
    Park KH; Shin DG; Kim JR; Hong JH; Cho KH
    Int J Mol Med; 2010 Jan; 25(1):129-36. PubMed ID: 19956911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
    Kotur-Stevuljevic J; Spasic S; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Stefanovic A; Vujovic A; Memon L; Kalimanovska-Ostric D
    Clin Biochem; 2008 Sep; 41(13):1067-73. PubMed ID: 18634772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of anaerobic training on paraoxonase-1 enzyme (PON1) activities of high density lipoprotein subgroups and its relationship with PON1-Q192R phenotype.
    Turgay F; Şişman AR; Aksu AÇ
    J Atheroscler Thromb; 2015; 22(3):313-26. PubMed ID: 25735253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity.
    Rozenberg O; Aviram M
    Biochem Biophys Res Commun; 2006 Dec; 351(2):492-8. PubMed ID: 17070779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paraoxonases-1, -2 and -3: What are their functions?
    Furlong CE; Marsillach J; Jarvik GP; Costa LG
    Chem Biol Interact; 2016 Nov; 259(Pt B):51-62. PubMed ID: 27238723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux.
    Gaidukov L; Rosenblat M; Aviram M; Tawfik DS
    J Lipid Res; 2006 Nov; 47(11):2492-502. PubMed ID: 16914770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of Paraoxonase1 in the Regulation of High-Density Lipoprotein Functionality and in Cardiovascular Protection.
    Khalil A; Fulop T; Berrougui H
    Antioxid Redox Signal; 2021 Jan; 34(3):191-200. PubMed ID: 31969002
    [No Abstract]   [Full Text] [Related]  

  • 54. Paraoxonase 1 (PON1) and stroke; the dilemma of genetic variation.
    Tajbakhsh A; Rezaee M; Rivandi M; Forouzanfar F; Afzaljavan F; Pasdar A
    Clin Biochem; 2017 Dec; 50(18):1298-1305. PubMed ID: 28779954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.
    Kakafika AI; Xenofontos S; Tsimihodimos V; Tambaki AP; Lourida ES; Kalaitzidis R; Cariolou MA; Elisaf M; Tselepis AD
    J Lipid Res; 2003 Oct; 44(10):1919-26. PubMed ID: 12867538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.
    Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E
    Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation.
    Shridas P; De Beer MC; Webb NR
    J Biol Chem; 2018 Aug; 293(34):13257-13269. PubMed ID: 29976759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.
    Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
    FEBS Lett; 1998 Feb; 423(1):57-60. PubMed ID: 9506841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.